GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D. Western Therapeutics Institute Inc (TSE:4576) » Definitions » Net Issuance of Preferred Stock

D. Western Therapeutics Institute (TSE:4576) Net Issuance of Preferred Stock : 円0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is D. Western Therapeutics Institute Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

D. Western Therapeutics Institute's net issuance of preferred for the three months ended in Dec. 2024 was 円0.0 Mil. The number is 0, which means that D. Western Therapeutics Institute has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

D. Western Therapeutics Institute's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was 円0.0 Mil.


D. Western Therapeutics Institute Net Issuance of Preferred Stock Historical Data

The historical data trend for D. Western Therapeutics Institute's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D. Western Therapeutics Institute Net Issuance of Preferred Stock Chart

D. Western Therapeutics Institute Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

D. Western Therapeutics Institute Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

D. Western Therapeutics Institute Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


D. Western Therapeutics Institute Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of D. Western Therapeutics Institute's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


D. Western Therapeutics Institute Business Description

Traded in Other Exchanges
N/A
Address
7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.

D. Western Therapeutics Institute Headlines

No Headlines